Individual susceptibility has a major impact on strong association between oxidative stress, defence systems and Parkinson's disease

The Role of Oxidative Stress in Parkinson’s Disease

(2020) Kuo-Hsuan Chang et al.   Antioxidants

BCPT policy for experimental and clinical studies

(2020) Pernille Tveden‐Nyborg et al.   BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY

The impacts of prominent gene polymorphisms in DNA repair enzymes on Parkinson’s disease

(2020) Nergis Selma Aslan et al.   NEUROSCIENCE LETTERS

Role of homocysteine in the development and progression of Parkinson’s disease

(2020) Xiaoyan Fan et al.   Annals of Clinical and Translational Neurology

XRCC1 protein; Form and function

(2019) Keith W. Caldecott   DNA REPAIR

Oxidative stress in the aging substantia nigra and the etiology of Parkinson's disease

(2019) Benjamin G. Trist et al.   AGING CELL

Oxidative stress and Parkinson’s disease: conflict of oxidant-antioxidant systems

(2019) Mohsen Hemmati-Dinarvand et al.   NEUROSCIENCE LETTERS

Plasma homocysteine, folate and vitamin B12 levels in Parkinson’s disease in China: A meta-analysis

(2019) Bao Dong et al.   CLINICAL NEUROLOGY AND NEUROSURGERY

Oxidative Stress in Parkinson's Disease: A Systematic Review and Meta-Analysis

(2018) Zexu Wei et al.   Frontiers in Molecular Neuroscience

In vivo ROS production and use of oxidative stress-derived biomarkers to detect the onset of diseases such as Alzheimer’s disease, Parkinson’s disease, and diabetes

(2017) Aya Umeno et al.   FREE RADICAL RESEARCH

Oxidative stress gene polymorphisms may have an impact in the development of ischemic stroke

(2017) Bensu Karahalil et al.   JOURNAL OF GENE MEDICINE

NADPH oxidases in Parkinson’s disease: a systematic review

(2017) Karim Belarbi et al.   Molecular Neurodegeneration

NADPH oxidase in brain injury and neurodegenerative disorders

(2017) Merry W. Ma et al.   Molecular Neurodegeneration

Association of plasma homocysteine, vitamin B12 and folate levels with cognitive function in Parkinson’s disease: A meta-analysis

(2017) Yi Xie et al.   NEUROSCIENCE LETTERS

Oxidative stress and cellular pathologies in Parkinson’s disease

(2017) Lesly Puspita et al.   Molecular Brain

The impact of detoxifying and repair gene polymorphisms on oxidative stress in ischemic stroke

(2016) Gürdal Orhan et al.   NEUROLOGICAL SCIENCES

Serum glutathione peroxidase, xanthine oxidase, and superoxide dismutase activities and malondialdehyde levels in patients with Parkinson’s disease

(2016) Burcu Gökçe Çokal et al.   NEUROLOGICAL SCIENCES

Highly specific changes in antioxidant levels and lipid peroxidation in Parkinson’s disease and its progression: Disease and staging biomarkers and new drug targets

(2016) Carine Coneglian de Farias et al.   NEUROSCIENCE LETTERS

Homocysteine Levels in Parkinson’s Disease: Is Entacapone Effective?

(2016) Bilge Kocer et al.   Biomed Research International

The impact of detoxifying and repair gene polymorphisms and the levels of serum ROS in the susceptibility to multiple sclerosis

(2015) Bensu Karahalil et al.   CLINICAL NEUROLOGY AND NEUROSURGERY

Associations between B Vitamins and Parkinson’s Disease

(2015) Liang Shen   Nutrients

ROS Function in Redox Signaling and Oxidative Stress

(2014) Michael Schieber et al.   CURRENT BIOLOGY

Induction of Hyperhomocysteinemia Models Vascular Dementia by Induction of Cerebral Microhemorrhages and Neuroinflammation

(2013) Tiffany L Sudduth et al.   JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM

Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling

(2012) Paul D. Ray et al.   CELLULAR SIGNALLING

Biochemistry, Physiology, and Pathophysiology of NADPH Oxidases in the Cardiovascular System

(2012) Bernard Lassègue et al.   CIRCULATION RESEARCH

The role of GSTM1, GSTT1, GSTP1, and OGG1 polymorphisms in type 2 diabetes mellitus risk: A case–control study in a Turkish population

(2012) Nüvit Gönül et al.   GENE

DNA Repair Genes in Parkinson's Disease

(2012) Mehmet Gencer et al.   Genetic Testing and Molecular Biomarkers

L-Dopa therapy increases homocysteine concentration in cerebrospinal fluid from patients with Parkinson’s disease

(2010) Chiaki Isobe et al.   JOURNAL OF CLINICAL NEUROSCIENCE

The impact of OGG1, MTH1 and MnSOD gene polymorphisms on 8-hydroxy-2′-deoxyguanosine and cellular superoxide dismutase activity in myocardial ischemia–reperfusion

(2010) Bensu Karahalil et al.   MOLECULAR BIOLOGY REPORTS

Associations between GSTM1 and OGG1 Ser326Cys polymorphisms and smoking on chromosomal damage and birth growth in mothers

(2010) Bensu Karahalil et al.   MOLECULAR BIOLOGY REPORTS

Urinary 8-hydroxydeoxyguanosine correlate with hallucinations rather than motor symptoms in Parkinson’s disease

(2010) Masaaki Hirayama et al.   PARKINSONISM & RELATED DISORDERS

Oxidative damage in Parkinson disease: Measurement using accurate biomarkers

(2009) Raymond C.S. Seet et al.   FREE RADICAL BIOLOGY AND MEDICINE

8-OHdG in Cerebrospinal Fluid as a Marker of Oxidative Stress in Various Neurodegenerative Diseases

(2009) K. Gmitterová et al.   Neurodegenerative Diseases